Literature DB >> 20379469

Clinical experience of the brushite calcium phosphate cement for the repair and augmentation of surgically induced cranial defects following the pterional craniotomy.

Cheol Ji1, Jae-Geun Ahn.   

Abstract

OBJECTIVE: To prevent temporal depression after the pterional craniotomy, this study was designed to examine the safety and aesthetic efficacy of the brushite calcium phosphate cement (CPC) in the repair and augmentation of bone defects following the pterional craniotomy.
METHODS: The brushite CPC was used for the repair of surgically induced cranial defects, with or without augmentation, in 17 cases of pterional approach between March, 2005 and December, 2006. The average follow-up month was 20 with range of 12-36 months. In the first 5 cases, bone defects were repaired with only brushite CPC following the contour of the original bone. In the next 12 cases, bone defects were augmented with the brushite CPC rather than original bone contour. For a stability monitoring of the implanted brushite CPC, post-implantation evaluations including serial X-ray, repeated physical examination for aesthetic efficacy, and three-dimensional computed tomography (3D-CT) were taken 1 year after the implantation.
RESULTS: The brushite CPC paste provided precise and easy contouring in restoration of the bony defect site. No adverse effects such as infection or inflammation were noticed during the follow-up periods from all patients. 3D-CT was taken 1 year subsequent to implantation showed good preservation of the brushite CPC restoration material. In the cases of the augmentation group, aesthetic outcomes were superior compared to the simple repair group.
CONCLUSION: The results of this clinical study indicate that the brushite CPC is a biocompatible alloplastic material, which is useful for prevention of temporal depression after pterional craniotomy. Additional study is required to determine the long-term stability and effectiveness of the brushite calcium phosphate cement for the replacement of bone.

Entities:  

Keywords:  Augmentation; Bony defect; Brushite calcium phosphate cement; Pterional craniotomy

Year:  2010        PMID: 20379469      PMCID: PMC2851085          DOI: 10.3340/jkns.2010.47.3.180

Source DB:  PubMed          Journal:  J Korean Neurosurg Soc        ISSN: 1225-8245


  20 in total

1.  Norian craniofacial repair system bone cement for the repair of craniofacial skeletal defects.

Authors:  M A Mahr; G B Bartley; U Bite; R P Clay; J L Kasperbauer; J M Holmes
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2000-09       Impact factor: 1.746

2.  Endoscopic cranioplasty with calcium phosphate cement for pterional bone defect after frontotemporal craniotomy: technical note.

Authors:  Shigeki Kubo; Hiroshi Takimoto; Amami Kato; Toshiki Yoshimine
Journal:  Neurosurgery       Date:  2002-10       Impact factor: 4.654

3.  BoneSource for craniomaxillofacial reconstruction.

Authors:  J B Turk; A Parhiscar
Journal:  Facial Plast Surg       Date:  2000       Impact factor: 1.446

4.  Frontozygomatic titanium cranioplasty in frontosphenotemporal ("pterional") craniotomy.

Authors:  Shaan M Raza; Quoc-Anh Thai; Gustavo Pradilla; Rafael J Tamargo
Journal:  Neurosurgery       Date:  2008-03       Impact factor: 4.654

5.  Biocompatibility and resorption of a brushite calcium phosphate cement.

Authors:  Felix Theiss; Detlef Apelt; Bastian Brand; Annette Kutter; Katalin Zlinszky; Marc Bohner; Sandro Matter; Christian Frei; Joerg A Auer; Brigitte von Rechenberg
Journal:  Biomaterials       Date:  2005-07       Impact factor: 12.479

6.  Hydroxyapatite cement in pediatric craniofacial reconstruction.

Authors:  Lisa David; Louis Argenta; David Fisher
Journal:  J Craniofac Surg       Date:  2005-01       Impact factor: 1.046

7.  A contraindication for the use of hydroxyapatite cement in the pediatric population.

Authors:  Damir Matic; John H Phillips
Journal:  Plast Reconstr Surg       Date:  2002-07       Impact factor: 4.730

8.  Cosmetic reconstruction of temporal defect following pterional [corrected] craniotomy.

Authors:  B Badie
Journal:  Surg Neurol       Date:  1996-04

9.  In vivo behavior of three different injectable hydraulic calcium phosphate cements.

Authors:  D Apelt; F Theiss; A O El-Warrak; K Zlinszky; R Bettschart-Wolfisberger; M Bohner; S Matter; J A Auer; B von Rechenberg
Journal:  Biomaterials       Date:  2004 Mar-Apr       Impact factor: 12.479

10.  Degradable injectable bone cement in maxillofacial surgery: indications and clinical experience in 27 patients.

Authors:  Klaus-Dietrich Wolff; Sami Swaid; Dirk Nolte; Roland A Böckmann; Frank Hölzle; Christian Müller-Mai
Journal:  J Craniomaxillofac Surg       Date:  2004-04       Impact factor: 2.078

View more
  3 in total

1.  Electrochemical characteristics of calcium-phosphatized AZ31 magnesium alloy in 0.9 % NaCl solution.

Authors:  Branislav Hadzima; Mansour Mhaede; Filip Pastorek
Journal:  J Mater Sci Mater Med       Date:  2014-01-30       Impact factor: 3.896

Review 2.  Biofunctionalization of metallic implants by calcium phosphate coatings.

Authors:  Yingchao Su; Irsalan Cockerill; Yufeng Zheng; Liping Tang; Yi-Xian Qin; Donghui Zhu
Journal:  Bioact Mater       Date:  2019-05-20

Review 3.  Esthetics outcomes in patients submitted to pterional craniotomy and its variants: A scoping review.

Authors:  Daniel Buzaglo Gonçalves; Maria Izabel Andrade Dos Santos; Lucas de Cristo Rojas Cabral; Louise Makarem Oliveira; Gabriela Campos da Silva Coutinho; Bruna Guimarães Dutra; Rodrigo Viana Martins; Franklin Reis; Wellingson Silva Paiva; Robson Luis Oliveira de Amorim
Journal:  Surg Neurol Int       Date:  2021-09-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.